Post by PMSI Strategy

PMSI is delighted to have provided the #CDD to support BGF's investment in Seda Pharmaceutical Development & Clinical Manufacturing Services. Seda is an integrated contract research, development and manufacturing organisation (CRDMO) providing end-to-end pharmaceutical development services – supporting companies from early-stage drug development through the clinical phases to registration. Congratulations to all involved! To hear more about this transaction and our other related experience, please contact Gareth Elliott. Read more here: https://lnkd.in/ek9dZQkb